Free Trial

USANA Health Sciences (USNA) Earnings Date, Estimates & Call Transcripts

$42.62
+0.78 (+1.86%)
(As of 07/26/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Oct. 22Estimated
Actual EPS
(Jul. 23)
$0.54 Missed By -$0.11
Consensus EPS
(Jul. 23)
$0.65
Skip Charts & View Estimated and Actual Earnings Data

USNA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

USNA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

USANA Health Sciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242$0.63$0.75$0.69 
Q2 20242$0.62$0.68$0.65 
Q3 20242$0.46$0.51$0.49 
Q4 20241$0.57$0.57$0.57 
FY 20247$2.28$2.51$2.40 
Q1 20251$0.80$0.80$0.80 
Q2 20251$0.70$0.70$0.70 
Q3 20251$0.73$0.73$0.73 
Q4 20251$0.81$0.81$0.81 
FY 20254$3.04$3.04 $3.04

USNA Earnings Date and Information

USANA Health Sciences last posted its quarterly earnings results on July 23rd, 2024. The reported $0.54 EPS for the quarter, missing analysts' consensus estimates of $0.65 by $0.11. The company had revenue of $212.87 million for the quarter, compared to the consensus estimate of $218.64 million. USANA Health Sciences has generated $3.21 earnings per share over the last year ($3.21 diluted earnings per share) and currently has a price-to-earnings ratio of 13.3. Earnings for USANA Health Sciences are expected to grow by 20.16% in the coming year, from $2.48 to $2.98 per share. USANA Health Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, October 22nd, 2024 based off prior year's report dates.

USANA Health Sciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
10/22/2024
(Estimated)
------- 
7/23/2024Q2 2024$0.65$0.54($0.11)$0.54$218.64 million$212.87 million    
4/30/2024Q1 2024$0.69$0.86+$0.17$0.86$223.27 million$227.80 million
2/6/2024Q4 2023$0.52$0.87+$0.35$0.87$206.70 million$221.08 million
10/24/2023Q3 2023$0.64$0.59($0.05)$0.59$212.24 million$213.37 million    
7/25/2023Q2 2023$0.70$0.89+$0.19$0.89$224.77 million$238.20 million    
4/25/2023Q1 2023$0.77$0.95+$0.18$0.95-$248.36 million
2/7/2023Q4 2022$0.35$0.66+$0.31$0.66-$227.96 million    
10/25/2022Q3 2022$0.89$0.78($0.11)$0.78$247.70 million$233.30 million
7/26/2022Q2 2022$1.05$1.00($0.05)$1.00$265.00 million$264.47 million    
4/26/2022Q1 2022$1.14$1.15+$0.01$1.15$270.80 million$272.87 million    
2/8/2022Q4 2021$1.30$1.03($0.27)$1.03$273.00 million$267.30 million    
10/26/2021Q3 2021$1.30$1.36+$0.06$1.36$268.70 million$274.35 million    
7/27/2021Q2 2021$1.78$1.87+$0.09$1.87$340.20 million$336.84 million    
4/27/2021Q1 2021$1.57$1.45($0.12)$1.45$300.40 million$307.98 million  
2/8/2021Q4 2020$1.39$1.87+$0.48$1.87$286.71 million$310.50 million  
10/20/2020Q3 2020$1.29$1.44+$0.15$1.44$281.80 million$298.50 million  
7/21/2020Q2 2020$1.08$1.32+$0.24$1.32$267.80 million$258.99 million  
4/21/2020Q1 2020$0.57$1.23+$0.66$1.23$220.40 million$266.62 million  
2/4/2020Q4 2019$0.98$1.41+$0.43$1.41$256.46 million$271.30 million  
10/22/2019Q3 2019$0.87$1.09+$0.22$1.09$256.22 million$260.60 million  

USANA Health Sciences Earnings - Frequently Asked Questions

When is USANA Health Sciences's earnings date?

USANA Health Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, October 22nd, 2024 based off last year's report dates. Learn more on USNA's earnings history.

What guidance has USANA Health Sciences issued on next quarter's earnings?

USANA Health Sciences issued an update on its FY 2024 earnings guidance on Tuesday, July, 23rd. The company provided EPS guidance of 2.400-2.550 for the period, compared to the consensus estimate of 2.780. The company issued revenue guidance of $850.0 million-$880.0 million, compared to the consensus revenue estimate of $883.5 million.

Did USANA Health Sciences beat their earnings estimates last quarter?

In the previous quarter, USANA Health Sciences (NYSE:USNA) missed the analysts' consensus estimate of $0.65 by $0.11 with a reported earnings per share (EPS) of $0.54. Learn more on analysts' earnings estimate vs. USNA's actual earnings.

How can I listen to USANA Health Sciences's earnings conference call?

The conference call for USANA Health Sciences's latest earnings report can be listened to online. Listen to Conference Call

How can I read USANA Health Sciences's conference call transcript?

The conference call transcript for USANA Health Sciences's latest earnings report can be read online. Read Transcript

How much revenue does USANA Health Sciences generate each year?

USANA Health Sciences (NYSE:USNA) has a recorded annual revenue of $921.01 million.

How much profit does USANA Health Sciences generate each year?

USANA Health Sciences (NYSE:USNA) has a recorded net income of $63.79 million. USNA has generated $3.21 earnings per share over the last four quarters.

What is USANA Health Sciences's price-to-earnings ratio?

USANA Health Sciences (NYSE:USNA) has a trailing price-to-earnings ratio of 13.28 and a forward price-to-earnings ratio of 17.19. The price/earnings-to-growth ratio is 1.5.

What is USANA Health Sciences's EPS forecast for next year?

USANA Health Sciences's earnings are expected to grow from $2.48 per share to $2.98 per share in the next year, which is a 20.16% increase.


More Earnings Resources from MarketBeat

This page (NYSE:USNA) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners